Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Diabetes Research and Clinical Practice|April 28, 2007
Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cellsYasuhiko Yamamoto, Hideto Yonekura, Takuo Watanabe, et al.
Cancer|September 26, 2003
REG gene expression is associated with the infiltrating growth of gastric carcinomaYutaka Yonemura, Shigeru Sakurai, Hiroshi Yamamoto, et al.
Journal of Alzheimer'S Disease : JAD|November 9, 2011
Endogenous secretory receptor for advanced glycation end-products inhibits amyloid-β1-42 uptake into mouse brainTakahiro Sugihara, Seiichi Munesue, Yasuhiko Yamamoto, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
The AGE-RAGE system and diabetic nephropathyShigeru Sakurai, Hideto Yonekura, Yasuhiko Yamamoto, et al.
Artificial Organs|October 13, 2009
The benefits of high-flow management in children with pulmonary atresiaYasuhiro Fujii, Yasuhiro Kotani, Takuya Kawabata, et al.
Diabetes Research and Clinical Practice|February 21, 2006
Development of an ELISA for esRAGE and its application to type 1 diabetic patientsShigeru Sakurai, Yasuhiko Yamamoto, Hironori Tamei, et al.
Journal of Molecular and Cellular Cardiology|October 24, 2002
Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytesRalica Petrova, Yasuhiko Yamamoto, Katsuhiko Muraki, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2018
Surgical outcomes of aortic repair via transapical cannulation and the adventitial inversion technique for acute Type A aortic dissectionJunichi Shimamura, Shin Yamamoto, Susumu Oshima, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Receptor for advanced glycation end products is a promising target of diabetic nephropathyYasuhiko Yamamoto, Toshio Doi, Ichiro Kato, et al.
Pageof 6